Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 159546

AbstractConclusionReferencesDOI and Others
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Reviews
Year : 2022 | Month : September | Volume : 16 | Issue : 9 | Page : OE01 - OE06 Full Version

A Review on Palliative Care Challenges and Benefits


Published: September 1, 2022 | DOI: https://doi.org/10.7860/JCDR/2022/58042.16904
Amit Agrawal, Dalwinder Singh, Roshan Chanchlani, Alejandro Pando

1. Associate Professor, Department of Paediatrics, Gandhi Medical College, Bhopal, Madhya Pradesh, India. 2. Neonatologist, Department of Paediatrics, Al Jalila Children's Speciality Hospital, Dubai, United Arab Emirates. 3. Associate Professor, Department of Paediatric Surgery, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh, India. 4. PhD Scholar, Department of Neurosurgery, Rutgers, New Jersey Medical School, New Jersey, USA.

Correspondence Address :
Amit Agrawal,
Gandhi Medical College and Kamla Nehru Hospital, Bhopal, Madhya Pradesh, India.
E-mail: agrawaldramit@yahoo.co.in

Abstract

Palliative care is a treatment strategy that aims to improve the quality of life of patients suffering from various serious illnesses. Palliative care is provided to these patients by experts from multidisciplinary fields utilising a holistic approach. It reduces the burden on families and patients by providing services related to pain management, early diagnosis and assessment, and by addressing their psychological, spiritual, ethical, and cultural issues. The aim of this narrative review is to cast light on the cost-effectiveness, evolution, and challenges of palliative care. Databases including Medline/PubMed and Google Scholar were searched to retrieve relevant studies including clinical trials, case studies, and meta-analyses and reviews. Information obtained from these studies includes cost-effectiveness, palliative care evolution, and palliative care-related social issues among patients and family members as well as healthcare professionals.The purpose of this narrative review is to summarise the barriers and recent advancements of palliative care in terminally ill patient care.

Keywords

Hospices, Hospice care, Patient care, Terminal care

The World Health Organization (WHO) defines Palliative care as “an approach that improves the quality of life of patients and that of their families who are facing challenges associated with life-threatening illness, whether physical, psychological, social or spiritual”. Palliative care is recognised as the basic health right of an individual (1). It takes a multipronged approach centered around the healthcare team, the patient and the patient’s family, while the patient advances from a deteriorating health condition to the last hours of his or her life (2). It is estimated that approximately 40 million people require palliative care each year, but worldwide only 14% receive this care (3).

Principles of palliative care are influenced by key areas such as type of service models adopted, care co-ordination among healthcare professionals, education and training for non hospital staff, equality to access for all patients, communication between healthcare professionals, patients and family at every stage, and responding to the specific needs of the patient and family (4). Palliative care has taken various forms since its genesis, and has progressed at a different pace in nations around the world.

In accordance with the National Consensus Project Clinical Practice Guidelines for Quality Palliative Care Guidelines 2018, palliative care seeks to address the following domains: structure and processes of care, physical, psychological, psychiatric, spiritual, religious, cultural, legal, ethical and existential aspects of the patient care, clinical implications and the holistic care of terminally-ill patients. Palliative care can begin in a local hospital, emergency room, community house, or residential setting. In diseases like cancer, clinicians generally advocate palliative care in the very early stages once the diagnosis has been established (5). According to a report, the demand for palliative care is expected to rise globally over the next 10 to 20 years due to changing demographics, emergence of chronic diseases, and high morbidity rates. Addressing pain demands going beyond the physical dilemmas, and in this review, we have summarised the cultural and ethical barriers to effective palliative care delivery.

Although palliative care has been recommended by worldwide accepted medical policies and frameworks, grant allocation for palliative care research has historically been significantly inadequate (6). For example, in 2013, the National Cancer Research Institute in the United Kingdom allocated 0.61% of its yearly research budget to palliative and End Of Life (EOL) care (7). Cost effectiveness is yet another challenge on the way to achieve quality palliative care services. According to the Global Atlas of palliative care, a large proportion of adult patients requiring palliative care suffer from cardiovascular diseases (38.5%), followed by cancer (34%), obstructive respiratory disease (10.3%), Human Immunodeficiency virus/Acquired Immuno-deficiency syndrome (HIV/AIDS) (5.7%) and diabetes (4.5%) (8). Cross culture competence among healthcare professionals and understanding of the various practice around the world can be a useful tool. For patients with a prognosis of six months or less, hospice care can be the healthcare strategy as it is similar to palliative care, when the goal is to avoid hospitalisation and to maximise time spent at home for patients nearing the end of their lives (9).

Unmet need of palliative care is an insurmountable issue. Increasing awareness among the health professionals, national policy makers and patients can ensure continuum of care for people with chronic and life-threatening diseases. In this review, authors aim to summarise the evolution of palliative care, its cost-effective profile, the barriers involving cultural and ethical issues. The review also sheds light on the issues surrounding implementation of palliative care in the rural settings. Finally, the review gives a brief summary on the status of do not resuscitate across nations around the world.

LITERATURE SEARCH STRATEGY

A literature search was performed using databases Medline/PubMed, and Google Scholar to retrieve the relevant studies including clinical trials, case studies, and meta-analyses and reviews. Information obtained from these studies includes cost-effectiveness, palliative care evolution, and palliative care-related social issues among patients and family members as well as healthcare professionals. The following combinations of keywords were used: palliative care and end-of-life care, evolution and progress in palliative care in the emergency departments, the cost-effectiveness of palliative care, challenges of palliative care in rural areas, and ethical, cultural, and spiritual issues in palliative care. The search was restricted to papers published in English.

EVOLUTION OF PALLIATIVE CARE

Evolution of palliative care in the United States (US) took place gradually with the development of innovative delivery models and resultant increase in demand for palliative care (10). Policy makers, health advocacy, public education, and philanthropic commitment are the primary drivers for the rooting of palliative care in the US. In comparison to the number of patients receiving community based palliative care, patients admitted to the hospital for palliative care are increasing since 2000 (11). According to a status report on palliative care, there has been steady growth with nearly universal access to public healthcare services in large US hospitals and medical institutions (10). Nonetheless, access to palliative care is still unequal and is influenced by geographical location and on the varying hospital facilities (number of beds, staff, etc.). Almost two-thirds of all hospitals in the US offer palliative care. Palliative care programmes were available in 90% of hospitals with 300 beds or more, compared to 56% of hospitals with fewer than 300 beds. Similarly, 67% of hospitals with 50 or more total facility beds reported having a palliative care programme. However, there are significant differences in palliative care policies and guidelines around the world, reflecting the huge discrepancy in pain medication access (11). Other barriers to palliative care implementation in developing and underdeveloped countries include a lack of exposure to palliative care content in medical curricula and misunderstanding with respect to its implementation (e.g. access to opioid analgesia will increase substance abuse) (12),(13).

In addition, there is a common misconception that palliative care can only be accessed by cancer patients or those nearing the end of their lives. Recognising that patients with chronic diseases experiencing pain, as well as other symptoms that are inadequately managed, has highlighted the importance of palliative care in both high and low resource settings (14). It has been observed that there is improvement in the quality of life among veterans following the implementation of a series of transformative healthcare structures, appreciationof the change in institutional culture, and better initiative by the Department of Veterans Affairs (VA). The VA’s strategic top-down and bottom-up approach to developing programs, policy proposals, and initiatives gives vital points of view and merits consideration in the broader US healthcare system (15). These efforts have paid off; studies show that the addition of palliative care in hospital facilities improves health satisfaction and family satisfaction, saves money, and reduces resource utilisation.

It is predicted that by 2060, there will be a global increase of atleast 87% in the serious illnesses appealing to palliative care interventions (13). According to the 2015 survey report, 37% of the countries had an operational national policy for Non Communicable Diseases (NCDs) that included palliative care. Palliative care services were financially disadvantaged when compared to other NCDs services and a large country-income gradient existed for palliative care funding, oral morphine availability, and palliative care integration at the primary levels of the health system (16). According to a 2017 World Health Organization (WHO) survey, 68% of countries have palliative care grants, and roughly one-third of countries reported that palliative care was generally provided by the primary healthcare facilities (35%) and community or home-based care (37%) (17). Countries in the Global North, accounting for 41% of the world’s population, have a high level of development in the palliative care services and while low-and middle-income countries account for 80% of the need for palliative care. Total 53•3% of the world’s population resides in the countries with very limited palliative care facilities; mainly in the Global South, though not exclusively. The rest (4•8%) is located in countries that have no known palliative care activity or building their set-ups, and in territories that were excluded in the survey (0•1%) (13).

COST-EFFECTIVENESS OF PALLIATIVE CARE

The cost-effectiveness of palliative care is well-documented in financially developed economies, and the favourable cost profile is always a powerful motivator to increase the supply of palliative care services in high-income societies. The percent of money saved at the hospital when palliative care is implemented ranges from 9% to 32% (18),(19). Studies have also elaborated on the monetary benefits for the healthcare system with the active implementation of palliative care (18),(19),(20). For patients discharged early and for patients whose death happened during the hospital stay, the savings the hospital could have had were $4098 and $7563, respectively (20). Cost analysis of the deaths that have occurred in the hospital have shown that when palliative care was instituted there was a 40% reduction in admission to the Intensive Care Units (ICUs) (21). On the contrary, in low and middle-income countries, there is lack of documentation on the cost-effectiveness of palliative care and it is a critical socioeconomic barrier to the availability of palliative care (22). Currently, the financial costs of incurable diseases are incompletely defined in low and middle-income countries, as well as in unstructured healthcare systems (23).

Furthermore, information about the cost-effectiveness of palliative care is an important factor to decide the financial expenditure of palliative care in low-income and middle-income nations, which will help in guiding health policy and endorse sustainable development. There are two approaches to compare the costs and outcomes of different interventions to direct public healthcare policy decisions at the population level: Cost-Effectiveness Analysis (CEAs) and Cost-Benefit Analysis (CBAs). CBAs aid in the conversion of impact into cost expenditure, whereas CEAs use health adaptation units to obtain a specific amount of output, such as Quality-Adjusted-Life-Years (QALYs), which measures the overall burden of disease (24). The CEA approach is widely used in global health policy to reduce the cost of high-quality medical care. As the prevalence of NCDs, HIV/AIDS, and cancer cases continues to rise in low and middle-income countries, CEA has proven to be a valuable and effective tool in developing models for implementing high-quality healthcare systems. In high-incidence settings, active case seeking in the community; particularly in rural areas with limited healthcare facilities, can considerably enhance diagnostic and treatment coverage (25). Examples include community-based HIV and tuberculosis screening with connection to care, Mycobacterium tuberculosis culture for HIV-infected individuals, cancer prevention and treatment, and lung cancer treatment.

The monetary burden of any disease has increased in high-economic countries for both patients and the community. Factual work and a cost-avoidance economic model have aided in determining the cost-effectiveness of palliative care. As a result, the provision of palliative care in high-income countries has increased in the last few decades for monetary reasons while also enriching the quality of life. There is still significant inconsistency on how services are provided to patients in terms of palliative care setting, team member composition, treatment options, and physician consultation (23),(26). In the absence of palliative care in low-and middle-income countries, uncontrolled pain and psychological sequelae for the sufferer and caregivers are common in the case of incurable disease and life end timing. Furthermore, personal and societal costs mount, sometimes insurmountably (27). These costs include not only direct expenses associated with illness, such as the cost of treatments and medication but also indirect and frequently hidden costs associated with illness.

Health economics is slowly making inroads as an integral part of the pedagogy and practice of palliative care, despite being an evolving concept. It is crucial to know the financial burden to the individuals as well as communities when faced with an ever-growing number of investigations for consultation and follow-up. It also includes travel expenses, job loss for patients and caregivers, and the sale of personal valuable assets such as a gold ornaments or a family home (28),(29). Furthermore, the sale of land and livestock, as well as unmanageable school fees for children, serve to reduce a family’s future earning potential while dealing with the burden of illnesses.

Ghoshal A et al., investigated the effectiveness and cost-effectiveness of home-based palliative care and discovered that they help reduce disease symptoms and increase the likelihood of dying at home rather than in a hospital (28). While admitting that more research into cost-effectiveness is needed, the authors concluded that their findings justify providing home-based palliative care for those who wish to die at home. Smith S et al., examined the costs and cost-effectiveness of palliative care and discovered that it was consistently less expensive than the alternative options (29).

CHALLENGES WITH PALLIATIVE CARE

Cultural Issues

Palliative care in a diverse society, both ethnically and culturally, require understanding from healthcare providers to respect and consider the specific cultures of their patients. Health professionals who learn about culture and ethnicity through dedication and knowledge are able to better manage their patients’ pain. They can assist families and patients in adjusting to the dying process. Understanding the patients’ and their families’ beliefs, experiences, and values improve the quality of patient care. Before reaching patients with a prognosis, healthcare providers should also understand the family’s and patients’ faith and religious beliefs (30). Religion and spirituality play a significant role in patients’ healthcare decisions; although, many health professionals overlook this factor or the functional impact it may have on the assessment and treatment of suffering and palliative care (31).

Dame Cecily Saunders founded the hospice care movement and recognised that unresolved emotional and spiritual issues exacerbate the agony of dying. Spirituality is an essential component of suffering and addressing spiritual care during palliative care is significant for the relief of pain and suffering in such patients (32). She referred to this as spiritual pain and claimed that it stemmed from a “desolate feeling of meaninglessness.” Finding meaning in one’s suffering is thus a healthy process that can help one cope with pain and other unpleasant symptoms.

Dying patients frequently wonder, “Was my life worthwhile?” “Did I make a difference?”. Different communities and societies have different cultural beliefs about the origin and role of pain, which influences patients’ reactions to their pain (33). Opioids, which are commonly used to alleviate pain, are not widely accepted or encouraged in many cultures. This is a difficult barrier to overcome because opioids are a common pharmacologic treatment for those in severe pain near the end of their lives. Alternative techniques that can be used in conjunction with opioids, such as herbs, cupping, moxibustion, and coining, must be known to health practitioners. In some cases, patients request that a spiritual healer use medicinal herbs in their treatment (34).

Ethical Issues

There are numerous ethical issues to consider when providing palliative care to patients nearing the end of their lives. By using their knowledge and skill, Primary Care Providers (PCPs) should identify ethical issues to avoid future conflicts, as well as assist patients in making medical decisions that take into account the patient’s values and preferences (35). The goal of medical ethics is to provide guidelines and codes for physicians regarding their duty, responsibility, and conduct, as well as common principles that overlap with other ethics, such as nursing ethics and bioethics. The main ethical principle for palliative care is respect for autonomy, non maleficence (the duty not to harm), and justice (36).

Respect for autonomy is defined as the patient’s independence in making treatment and disease management decisions. Patients who are terminally ill will make decisions about their care and plan for the future. Patients, on the other hand, lack the autonomy to direct a health provider to give a lethal injection (37). Furthermore, case law establishes that a patient may not demand treatment that a physician deems to be inconvenient or not in the patient’s best interests. The physician, in consultation with the patient or caregivers, still makes the decision to treat. A competent patient has a right to refuse therapy despite knowing that doing so may result in the patient’s death. If a patient requests a lethal treatment, other ethical principles, such as non maleficence, will be violated (38).

Non maleficence- as per the principle, it should always be remembered that there are a variety of therapy courses that may have unintended side effects but may ultimately improve one’s life (39). As a result, the scope of the ‘harm’ or burden must be defined, as must the concept of whether death is an acceptable ‘harm’. This duty states that any action taken by a healthcare worker should always result in a net benefit to the patient’s quality of life. The burden of treatment is not always easy to anticipate and if a treatment is extremely strenuous, it may not be in the individual interest to continue.

Justice is defined as the equitable and fair distribution of resources. It is especially important in cases where patients cannot afford expensive treatments (40).

The application of ethical principles may aid in balancing competing interests. Collusion is a very common practice in cancer cases, where family members ask for favorable treatment that keeps the truth from patients. Although it is extremely difficult in today’s scientific environment, concealing disease information from the patient was an acceptable normuntil the last half-century (41). Over the time, the increase in patient autonomy in well-educated public, has changed the traditional practices in the western countries, and the open disclosure norm is now more popular (42). Still, many institutions continue to take a cautious approach, and it is not uncommon for family members to be informed before the patient.

The main factors involved in the patient-doctor relationship are respect to the patient’s self-determination and autonomy heritage (43). Although it is meant to protect the patient’s interests, it can be a cause of distress and disagreement in the ethical quandaries. Moral distress is the term used to describe stress caused by ethical quandaries. It refers to a moral agent’s inability to act in accordance with his own core values and perceived obligations as a result of internal and external constraints (44). In some countries; especially, the Middle East countries, religious and cultural practices have an important influence on the final decision made by the healthcare practitioner (45),(46).

Recent study showed that atleast one third of the family caregivers face personal and emotional pressure and burden of decision with doubt and guilt which can be a possible cause of depression, grief and unhappiness. Family caregiver burden was reported in terms of decision-making burdens, lack of certainty about the patients’ last wishes and values, and differing desires for the place of death. Withholding and withdrawing treatment, pain medication use, clear communication of disease and treatment, hydration, and nutrition are all stressful and difficult ethical issues in family care (47). A survey conducted in the Norwegian nursing homes describes the unavoidable presence of ethical issues while making EOL decisions. It was observed that ensuring patient autonomy and integrity without any breach in the freedom of patient to choose about the EOL decision are common ethical dilemmas in most of the nursing homes (48).

Issues in the Rural setting

Rural communities are interconnected networks of social solidarity, commitment, and networks (49). Although rural areas are advantageous in many ways such as local support networks, access to quality EOL care becomes difficult due to limited availability of healthcare services. Rural palliative care is essentially a primary care only, with limited access to multidisciplinary specialist palliative care services (50).

Most rural residents prefer to die at home; however, if this is not possible, nearby hospitals and aged home care are considered as alternatives. The universal rural theme is that if rural residents are unable to die at home, they must die in their community. Guidelines and working models for implementing palliative care in rural areas are severely limited. The majority of models are implemented in urban tertiary hospitals by teams of trained clinicians and healthcare workers from a variety of disciplines (51). Because patient volumes in urban areas are large enough to allow a team to focus on palliative medicine and have a greater proclivity to support hospital and community-based palliative care programs than in rural areas. According to previous literature, community-based palliative care programs are also very good and assist individuals in lowering costs and minimizing hospital utilisation (52). They also provide healthcare services almost anywhere patients go, such as clinics, homes, and nursing homes.

A community-based model of palliative care in rural areas allows health workers to better understand patients’ needs across the care continuum and can help align services to address clinical and non clinical needs through collaboration with an array of organisations. Community capacity-based planning, co-ordination among healthcare settings and community services, and clinical skill development through workforce training are three critical processes for meeting palliative care requirements in rural communities (53). Many unique challenges exist in rural settings in receiving quality EOL care such as distance, traveling, access to home-based services, lack of local specialists or experts, and lack of allied health support.

Patients in rural areas must travel for treatment, diagnosis, and follow-up, which can be stressful, expensive, uncomfortable, and exhausting at times, and dangerous and difficult at others due to weather or a poor road system (54). Family caregivers must take time off from work to visit the patient, and travel to distant hospitals (55). These issues always cause a quandary in caregivers’ decisions about whether to seek medical care locally or in a more distant location where experts and facilities are available. Access to in-home healthcare and support remains a major hurdle, due to seasonal barriers and lack of digital services in remote locations.

Access to allied healthcare services is also limited in rural areas. The availability of physiotherapy, counsellors, home nursing facilities, and social work varies by location and population (56). While some facilities are available in rural areas, they are frequently limited to hospitalisation at a local hospital or the cost of a private fee. Community pharmacists play an important role however, they are not available very frequently in all rural areas. The various barriers to palliative care have been depicted in the image. The three main issues are cultural, ethical and the implementation of palliative care to the rural settings (Table/Fig 1).

STATUS OF DO NOT RESUSCITATE (DNR) ORDERS IN DIFFERENT COUNTRIES

A DNR order was a commonly used term in ICUs and is getting obsolete in current era as it may give misimpression to the patients and family that the attempt to resuscitation is likely to succeed. Do Not Attempt to Resuscitate (DNAR) clearly indicates that an attempt to resuscitate the patient should not bemade where it is unlikely to be of any benefit. Allow Natural Death (AND) is another term which clearly affirms that the patient wants to follow a natural course of the disease to death and it is commonly employed in hospice patient alliance hospitals. Life Extending Treatments (LET) are usually employed in ICU in any critically ill patients; however, it might not be very useful in a palliative care setting. Here, LET can be limited by withholding future therapy or by withdrawing the current therapy while the aim is to provide consistent care to the dying patients (57),(58),(59).

The status of palliative care practices and EOL decisions vary from one country to another and it is influenced by various factors. In the US, limitation of life therapy that covers withholding and withdrawal of life support is a predominant practice in the ICUs (60). In contrast, DNR orders and withholding of life sustaining therapies are not commonly practiced norms in Brazil due to the lack of specific legislation and clinical guidelines (61). A prospective study conducted in Hong Kong has reflected that withholding of therapy compared to withdrawal of therapy occurred more frequently in the Asian population than in the Western populations (62). Religion, culture, family, and a physician’s educational background may all have an influence on patient decisions in Middle Eastern countries. Based on their age and ethnicity, patient attributes have a higher influence on LET and AND decisions (45),(63),(64).

In Korea, LET is recommended when death is obvious consequently this poses a time constraint on the family, care takers and the health professionals for taking an EOL decision (65). Slower EOL judgments were linked to longer ICU stays, implying that EOL patients require a faster, more immediate decision. The first law ‘the Leonetti law’ concerning the rights of patients at the EOL was proposed in April 2005 which allows the ‘limitation or discontinuation of treatment and sedation for a symptom that has remained refractory until death’. On February 2, 2016, the French government enacted the Claeys-Leonetti law introducing the right to deep and continuous sedation and forbade euthanasia for end-of-life patients (66).

A lack of national health policy in most countries supporting palliative care is also a barrier to the development of palliative care and status of palliative care varies greatly amongst different countries under international law, the majority of nations such as Mexico, has adopted legislation that is concordant with stipulations in the Universal Declaration of Human Rights (67). In the US, the development of palliative care services has been largely influenced by the fee-for-service system. The two primary models of palliative care that exist within hospitals are interdisciplinary consultation teams and inpatient units (68). Palliative care services are being expanded in developing countries but are still in their infancy in many countries like Indonesia, Pakistan and Nigeria (69),(70),(71). According to Yin Z et al., access to palliative care is extremely limited in China and the major barriers were lack of training opportunities, stigma on death and dying, and lack of resources and policies to support clinical practice (72). Palliative care has been present in India for more than 20 years; however, there is lack of uniformity in the practices and availability is limited to some centers only (73). There is significant inconsistency in how services are provided to patients in terms of palliative care setting, team member composition, treatment options, and physician consultation (30),(32). Furthermore, it has been discovered that providing education regarding use and benefits of these services can increase the use of palliative care in a culturally diverse population (74). Many general practitioners believe that cultural beliefs are as important as pain and symptom control in palliative care, but they lack confidence in managing cultural, spiritual, and ethical issues. There is a need for specially trained general practitioners in palliative care (30),(31).

Conclusion

Palliative care encompasses treatment of the underlying disease along with pain management in EOL. Palliative care has undergone significant changes, with varying improvements among countries across the world. Although, the developed nations have made huge leaps forward, barriers to effective palliative care in the low-and middle-income countries remain unanswered. A well-designed cost effectiveness profile of palliative care can drive its implementation across nations. Cultural issues, spiritual needs of patient and ethical intricacies impede the progress of palliative care services. Structured training in palliative care, knowledge of the local problems, and good communication skills among healthcare providers can aid to address these issues.

References

1.
Who.int. WHO | WHO Definition of Palliative Care. Available at: http://www.Who.Int/Cancer/Palliative/Definition/En/. 2012.
2.
Shinde T, Damani A, Ghoshal A, Muckaden MA, Deodhar J. Role of respite palliative care in understanding and managing complex palliative care situation -A case report. Indian J Palliat Care. 2022;28(1):120-23. [crossref] [PubMed]
3.
Sepúlveda C, Marlin A, Yoshida T, Ullrich A. Palliative care: The world health organization’s global perspective. J Pain Symptom Manage. 2002;24(2):91-96. [crossref]
4.
Hasson F, Nicholson E, Muldrew D, Bamidele O, Payne S, McIlfatrick S. International palliative care research priorities: A systematic review. BMC Palliat Care. 2020;19(1):16. [crossref] [PubMed]
5.
Ferrell BR, Twaddle ML, Melnick A, Meier DE. National consensus project clinical practice guidelines for quality palliative care guidelines. J Palliat Med. 2018;21(12):1684-89. [crossref] [PubMed]
6.
Knaul FM, Farmer PE, Krakauer EL, De Lima L, Bhadelia A, Jiang Kwete X, et al. Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: The Lancet Commission Report. The Lancet. 2018;391(10128):1391-54. [crossref]
7.
McIlfatrick S, Muldrew DHL, Hasson F, Payne S. Examining palliative and end of life care research in Ireland within a global context: A systematic mapping review of the evidence. BMC Palliat Care. 2018;17(1):109. [crossref] [PubMed]
8.
Daya A, Sarkar S, Kar S. Estimation of palliative care need in the urban community of Puducherry. Indian J Palliat Care. 2017;23(1):81-87. [crossref] [PubMed]
9.
Tatum PE, Mills SS. Hospice and palliative care: An overview. Med Clin North Am. 2020;104(3):359-73. [crossref] [PubMed]
10.
Dumanovsky T, Augustin R, Rogers M, Lettang K, Meier DE, Morrison RS, et al. The growth of palliative care in U.S. Hospitals: A status report. J Palliat Med. 2016;19(1):08-15. [crossref] [PubMed]
11.
Ntizimira CR, Nkurikiyimfura JL, Mukeshimana O, Ngizwenayo S, Mukasahaha D, Clancy C, et al. Palliative care in Africa: A global challenge. Ecancermedicalscience. 2014;8:493. [crossref] [PubMed]
12.
Cherny NI, Cleary J, Scholten W, Radbruch L, Torode J. The global opioid policy initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the middle east: Introduction and methodology. Annals Oncol. 2013;24(Supplementary xi):07-13. [crossref] [PubMed]
13.
Clark D, Baur N, Clelland D, Garralda E, López-Fidalgo J, Connor S, et al. Mapping levels of palliative care development in 198 countries: The situation in 2017. J Pain Symptom Manage. 2020;59(4):794-07. [crossref] [PubMed]
14.
May P, Normand C, Cassel JB, Del Fabbro E, Fine RL, Menz R, et al. Economics of palliative care for hospitalized adults with serious illness: A meta-analysis. JAMA Intern Med. 2018;178(6):820-29. [crossref] [PubMed]
15.
Sullivan DR, Teno JM, Reinke LF. Evolution of palliative care in the department of veterans affairs: Lessons from an Integrated Health Care Model. J Palliat Med. 2022;25(1):15-20. [crossref] [PubMed]
16.
Palliative care for non-communicable diseases: A global snapshot in 2015: summary of results from the 2015 WHO NCD country capacity survey [Internet]. [cited 2022 Jun 23]. Available from: https://apps.who.int/iris/handle/10665/206513.
17.
Sharkey L, Loring B, Cowan M, Riley L, Krakauer EL. National palliative care capacities around the world: Results from the World Health Organization Noncommunicable Disease Country Capacity Survey. Palliat Med. 2018;32(1):106-13. [crossref] [PubMed]
18.
May P, Garrido MM, Cassel JB, Kelley AS, Meier DE, Normand C, et al. Prospective cohort study of hospital palliative care teams for inpatients with advanced cancer: Earlier consultation is associated with larger cost-saving effect. J Clin Oncol. 2015;33(25):2745-52. [crossref] [PubMed]
19.
May P, Garrido MM, Cassel JB, Kelley AS, Meier DE, Normand C, et al. Palliative care teams’ cost-saving effect is larger for cancer patients with higher numbers of comorbidities. Health Aff. 2016;35(1):44-53. [crossref] [PubMed]
20.
Morrison RS, Dietrich J, Ladwig S, Quill T, Sacco J, Tangeman J, et al. The care span: Palliative care consultation teams cut hospital costs for Medicaid beneficiaries. Health Aff. 2011;30(3):454-63. [crossref] [PubMed]
21.
Penrod JD, Deb P, Luhrs C, Dellenbaugh C, Zhu CW, Hochman T, et al. Cost and utilization outcomes of patients receiving hospital-based palliative care consultation. J Palliat Med. 2006;9(4):973-79. [crossref] [PubMed]
22.
Reid EA, Kovalerchik O, Jubanyik K, Brown S, Hersey D, Grant L, et al. Is palliative care cost-effective in low-income and middle-income countries? A mixed-methods systematic review. BMJ Support Palliat Care. 2019;9(2):120-29. [crossref] [PubMed]
23.
Dalal S, Bruera E. End-of-life care matters: Palliative cancer care results in better care and lower costs. Oncologist. 2017;22(4):361-68. [crossref] [PubMed]
24.
Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes, 3 ed., Oxford University Press. 2005. [cited 2022 Jun 23]. https://EconPapers.repec.org/RePEc:oxp:obooks:9780198529453.
25.
Gilbert JA, Shenoi SV, Moll AP, Friedland GH, Paltiel AD, Galvani AP. Cost-effectiveness of community-based TB/HIV screening and linkage to care in rural South Africa. PLoS One. 2016;11(12):e0165614. [crossref] [PubMed]
26.
Zimmermann C, Riechelmann R, Krzyzanowska M, Rodin G, Tannock I. Effectiveness of specialized palliative care: A systematic review. JAMA-J Am Med Assoc. 2008;299(14):1698-09. [crossref] [PubMed]
27.
Reid EA, Gudina EK, Ayers N, Tigineh W, Azmera YM. Caring for life-limiting illness in Ethiopia: A mixed-methods assessment of outpatient palliative care needs. J Palliat Med. 2018;21(5):622-30. [crossref] [PubMed]
28.
Ghoshal A, Damani A, Salins N, Deodhar J, Muckaden MA. Economics of palliative and end-of-life care in India: A concept paper. Indian J Palliat Care. 2017;23(4):456-61. [crossref] [PubMed]
29.
Smith S, Brick A, O’Hara S, Normand C. Evidence on the cost and cost-effectiveness of palliative care: A literature review. Palliat Med. 2014;28(2):130-50. [crossref] [PubMed]
30.
Martin EM, Barkley TW. Improving cultural competence in end-of-life pain management. Nursing. 2016;46(1):32-41. [crossref] [PubMed]
31.
Hawley P. Barriers to access to palliative care. Palliat Care. 2017;10: 1178224216688887. [crossref] [PubMed]
32.
Lunn JS. Spiritual care in a multi-religious context. J Pain Palliat Care Pharmacoth. 2004;17(3-4):153-66. [crossref]
33.
Giezendanner S, Jung C, Banderet HR, Otte IC, Gudat H, Haller DM, et al. General practitioners’ attitudes towards essential competencies in end-of-life care: A cross-sectional survey. PLoS One. 2017;12(2):e0170168. [crossref] [PubMed]
34.
Saini S, Bhatnagar S. Cancer pain management in developing countries. Indian J Palliat Care. 2016;22(4):372-77. [crossref] [PubMed]
35.
Chukwuneke FN. Ethics of palliative care in late-stage cancer management and end-of-life issues in a depressed economy. Nigerian J Clin Pract. 2015;18(7):15-19. [crossref] [PubMed]
36.
Marty CM, Carter BS. Ethics and palliative care in the perinatal world. Sem Fetal Neonat Med. 2018;23(1):35-38. [crossref] [PubMed]
37.
Grignoli N, Di Bernardo V, Malacrida R. New perspectives on substituted relational autonomy for shared decision-making in critical care. Crit Care. 2018;22(1):260. [crossref] [PubMed]
38.
Kim M. The Problems and the Improvement Plan of the Hospice/Palliative Care and Dying Patient’s Decisions on Life-Sustaining Treatment Act. Korean J Hosp Palliat Care. 2018;21(1):01-08. [crossref]
39.
Cerminara KL. The law and its interaction with medical ethics in end-of-life decision making. Chest. 2011;140(3):775-80. [crossref] [PubMed]
40.
Barker P. Ethical dilemmas in palliative care. InnovAiT Educ Inspir Gen Pract. 2017;10(8):489-92. [crossref]
41.
Novack DH, Plumer R, Smith RL, Morrow GR, Ochitill H, Bennett JM. Changes in physicians’ attitudes toward telling the cancer patient. JAMA J Am Med Assoc. 1979;241(9):897-900. [crossref]
42.
Sen M. Communication with cancer patients. The influence of age, gender, education, and health insurance status. Ann N Y Acad Sci. 1997;809:514-24. [crossref] [PubMed]
43.
Youn G. Ethical considerations in hospice and palliative care research. Korean J Hosp Palliat Care. 2019;22(2):49-66. [crossref]
44.
Breslin JM, MacRae SK, Bell J, Singer PA. Top 10 health care ethics challenges facing the public: Views of Toronto bioethicists. BMC Med Ethics. 2005;6:E5. [crossref] [PubMed]
45.
Gouda A, Al-Jabbary A, Fong L. Compliance with DNR policy in a tertiary care center in Saudi Arabia. Intensive Care Med. 2010;36(12):2149-53. [crossref] [PubMed]
46.
Phua J, Joynt GM, Nishimura M, Deng Y, Myatra SN, Chan YH, et al. Withholding and withdrawal of life-sustaining treatments in low-middle-income versus high-income Asian countries and regions. Intensive Care Med. 2016;42(7):1118-27. [crossref] [PubMed]
47.
Hamano J, Morita T, Mori M, Igarashi N, Shima Y, Miyashita M. Prevalence and predictors of conflict in the families of patients with advanced cancer: A nationwide survey of bereaved family members. Psychooncology. 2018;27(1):302-08. [crossref] [PubMed]
48.
Gjerberg E, Førde R, Pedersen R, Bollig G. Ethical challenges in the provision of end-of-life care in Norwegian nursing homes. Soc Sci Med. 2010;71(4):677-84. [crossref] [PubMed]
49.
Devik SA, Hellzen O, Enmarker I. Picking up the pieces - Meanings of receiving home nursing care when being old and living with advanced cancer in a rural area. Int J Qual Stud Health Well-being. 2015;10:28382. Doi: 10.3402/qhw.v10.28382. [crossref] [PubMed]
50.
Douthit N, Kiv S, Dwolatzky T, Biswas S. Exposing some important barriers to health care access in the rural USA. Public Health. 2015;129(6):611-20. [crossref] [PubMed]
52.
Lockie SJ, Bottorff JL, Robinson CA, Pesut B. Experiences of rural family caregivers who assist with commuting for palliative care. Can J Nurs Res. 2010;42(1):74-91.
52.
Kang JH, Jung CY, Park K-S, Huh JS, Oh SY, Kwon JH. Community care for cancer patients in rural areas: An integrated regional cancer center and public health center partnership model. Korean J Hosp Palliat Care. 2021;24(4):226-34. [crossref]
53.
Giesbrecht M, Crooks VA, Castleden H, Schuurman N, Skinner M, Williams A. Palliating inside the lines: The effects of borders and boundaries on palliative care in rural Canada. Soc Sci Med. 2016;168:273-82. [crossref] [PubMed]
54.
Pesut B, Robinson CA, Bottorff JL, Fyles G, Broughton S. On the road again: Patient perspectives on commuting for palliative care. Palliat Support Care. 2010;8(2):187-95. [crossref] [PubMed]
55.
Schulz R, Beach SR, Czaja SJ, Martire LM, Monin JK. Family caregiving for older adults. Annual Rev Psychol. 2020;71:635-59. [crossref] [PubMed]
56.
Yosick L, Crook RE, Gatto M, Maxwell TL, Duncan I, Ahmed T, et al. Effects of a population health community-based palliative care program on cost and utilization. J Palliat Med. 2019;22(9):1075-81. [crossref] [PubMed]
57.
Saban M, Patito H, Zaretsky L, Salama R, Darawsha A. Emergency department mortality: Fair and square. Am J Emerg Med. 2019;37(6):1020-24. [crossref] [PubMed]
58.
Breault JL. DNR, DNAR, or AND? Is language important? Ochsner J. 2011;11(4):304-06.
59.
Rubenfeld GD. Principles and practice of withdrawing life-sustaining treatments. Crit Care Clin. 2004;20(3):435-51. [crossref] [PubMed]
60.
Prendergast TJ, Claessens MT, Luce JM. A national survey of end-of-life care for critically ill patients. Am J Respir Crit Care Med. 1998;158(4):1163-67. [crossref] [PubMed]
61.
Soares M, Terzi RGG, Piva JP. End-of-life care in Brazil. Intensive Care Med. 2007;33(6):1014-17. [crossref] [PubMed]
62.
Buckley TA, Joynt GM, Tan PYH, Cheng CAY, Yap FHY. Limitation of life support: Frequency and practice in a Hong Kong intensive care unit. Crit Care Med. 2004;32(2):415-20. [crossref] [PubMed]
63.
Aldawood AS, Alsultan M, Arabi YM, Baharoon SA, Al-Qahtani M, Haddad SH, et al. End-of-life practices in a tertiary intensive care unit in Saudi Arabia. Anaesth Intensive Care. 2012;40(1):137-41. [crossref] [PubMed]
64.
Yazigi A, Riachi M, Dabbar G. Withholding and withdrawal of life-sustaining treatment in a Lebanese intensive care unit: A prospective observational study. Intensive Care Med. 2005;31(4):562-67. [crossref] [PubMed]
65.
Kim S, Lim A, Jang H, Jeon M. Life-sustaining treatment decision in palliative care based on electronic health records analysis. J Clin Nurs. 2022 Jan 12. doi: 10.1111/jocn.16206. Online ahead of print. [crossref] [PubMed]
66.
De Nonneville A, Marin A, Chabal T, Tuzzolino V, Fichaux M, Salas S, et al. End-of-life practices in france under the claeys-leonetti law: Report of three cases in the oncology unit. Case Rep Oncol. 2016;9(3):650-54. [crossref] [PubMed]
67.
Bistre S. New legislation on palliative care and pain in Mexico. J Pain Palliat Care Pharmacoth. 2009;23(4):415-25. [crossref] [PubMed]
68.
Morrison RS. Models of palliative care delivery in the United States. Current Opinion Supportive Palliat Care. 2013;7(2):201-06. [crossref] [PubMed]
69.
Rochmawati E, Wiechula R, Cameron K. Current status of palliative care services in Indonesia: A literature review. International Nursing Review. 2016;63(2):180-190. [crossref] [PubMed]
70.
Tariq SM, Hasan M, Haider SA. Palliative medicine in Pakistan: A developing country’s perspective. Ochsner J. 2018;18(2):114. [crossref] [PubMed]
71.
Onyeka TC. Palliative care in Enugu, Nigeria: Challenges to a new practice. Indian J Palliat Care. 2011;17(2):131-136. [crossref] [PubMed]
72.
Yin Z, Li J, Ma K, Ning X, Chen H, Fu H, et al. Development of palliative care in China: A tale of three cities. Oncologist. 2017;22(11):1362-67. [crossref] [PubMed]
73.
Khosla D, Patel FD, Sharma SC. Palliative care in India: Current progress and future needs. Indian Journal of Palliative Care. 2012;18(3)149-54. [crossref] [PubMed]
74.
Cultural aspects of palliative care-UpToDate [Internet]. [cited 2022 Jun 23]. Available from: https://www.uptodate.com/contents/cultural-aspects-of-palliative-care.

DOI and Others

DOI: 10.7860/JCDR/2022/58042.16904

Date of Submission: May 31, 2022
Date of Peer Review: Jun 23, 2022
Date of Acceptance: Jun 29, 2022
Date of Publishing: Sep 01, 2022

AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? NA
• For any images presented appropriate consent has been obtained from the subjects. NA

PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Jun 01, 2022
• Manual Googling: Jun 29, 2022
• iThenticate Software: Aug 30, 2022 (13%)

ETYMOLOGY: Author Origin

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com